Recently, it has been found that mutations in TET2 and DNMT3A are frequently present in CAVD patients11, and this is linked to an increase in the inflammatory signature of circulating monocytes12 and to alterations in the number of circulating pro-inflammatory T cells11. The gene discussed is DNMT3A; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.